JP2023502968A5 - - Google Patents
Info
- Publication number
- JP2023502968A5 JP2023502968A5 JP2022528305A JP2022528305A JP2023502968A5 JP 2023502968 A5 JP2023502968 A5 JP 2023502968A5 JP 2022528305 A JP2022528305 A JP 2022528305A JP 2022528305 A JP2022528305 A JP 2022528305A JP 2023502968 A5 JP2023502968 A5 JP 2023502968A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025104401A JP2025134876A (ja) | 2019-11-15 | 2025-06-20 | アミロイド沈着物を標的化するための修飾免疫グロブリン |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962936002P | 2019-11-15 | 2019-11-15 | |
| US62/936,002 | 2019-11-15 | ||
| US202063074912P | 2020-09-04 | 2020-09-04 | |
| US63/074,912 | 2020-09-04 | ||
| PCT/US2020/060596 WO2021097360A1 (en) | 2019-11-15 | 2020-11-13 | Modified immunoglobulins for targeting amyloid deposits |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025104401A Division JP2025134876A (ja) | 2019-11-15 | 2025-06-20 | アミロイド沈着物を標的化するための修飾免疫グロブリン |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023502968A JP2023502968A (ja) | 2023-01-26 |
| JP2023502968A5 true JP2023502968A5 (https=) | 2023-11-20 |
| JPWO2021097360A5 JPWO2021097360A5 (https=) | 2023-11-20 |
| JP7722990B2 JP7722990B2 (ja) | 2025-08-13 |
Family
ID=75912899
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022528305A Active JP7722990B2 (ja) | 2019-11-15 | 2020-11-13 | アミロイド沈着物を標的化するための修飾免疫グロブリン |
| JP2025104401A Pending JP2025134876A (ja) | 2019-11-15 | 2025-06-20 | アミロイド沈着物を標的化するための修飾免疫グロブリン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025104401A Pending JP2025134876A (ja) | 2019-11-15 | 2025-06-20 | アミロイド沈着物を標的化するための修飾免疫グロブリン |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US20220411489A1 (https=) |
| EP (1) | EP4058479A4 (https=) |
| JP (2) | JP7722990B2 (https=) |
| KR (1) | KR20220113950A (https=) |
| CN (1) | CN115298214A (https=) |
| AU (1) | AU2020385183A1 (https=) |
| BR (1) | BR112022009273A2 (https=) |
| CA (1) | CA3158206A1 (https=) |
| IL (1) | IL292903B2 (https=) |
| MX (1) | MX2022005850A (https=) |
| WO (1) | WO2021097360A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4058479A4 (en) | 2019-11-15 | 2024-02-28 | University of Tennessee Research Foundation | MODIFIED IMMUNOLOBULINES FOR TARGETING AMYLOID DEPOSITS |
| WO2022120378A1 (en) * | 2020-12-04 | 2022-06-09 | University Of Tennessee Research Foundation | Method for diagnosing amyloid diseases |
| JP2024519488A (ja) * | 2021-05-05 | 2024-05-14 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | アミロイド疾患を治療するためのペプチド－ｆｃ融合体 |
| JP2024521082A (ja) * | 2021-05-18 | 2024-05-28 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | アミロイド障害を処置するための抗体－ペプチド融合タンパク質 |
| AU2022346750A1 (en) * | 2021-09-14 | 2024-04-11 | Caelum Biosciences, Inc. | Method of treating multiple myeloma |
| EP4430071A4 (en) * | 2021-11-12 | 2026-01-14 | Adrx Inc | ANTIBODIES BINDING TO THE TRANSTHYRETIN (TTR) MONOMER |
| US20250298033A1 (en) * | 2022-05-11 | 2025-09-25 | Alexion Pharmaceuticals, Inc. | High sensitivity biotinylated peptide binding elisa assay |
| US20260070962A1 (en) * | 2022-09-02 | 2026-03-12 | University Of Tennessee Research Foundation | Chimeric antigen receptors for removal of amyloid |
| AU2024339036A1 (en) | 2023-09-07 | 2026-03-12 | University Of Tennessee Research Foundation | Method for diagnosing amyloid diseases |
| WO2025212955A1 (en) | 2024-04-05 | 2025-10-09 | University Of Tennessee Research Foundation | Method for diagnosing amyloid diseases |
| WO2026055521A1 (en) * | 2024-09-06 | 2026-03-12 | University Of Tennessee Research Foundation | Antibody-peptide fusion proteins for treating amyloid disorders |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| WO1993006217A1 (en) | 1991-09-19 | 1993-04-01 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| EP0733070A1 (en) * | 1993-12-08 | 1996-09-25 | Genzyme Corporation | Process for generating specific antibodies |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
| DE69942274D1 (de) * | 1998-05-21 | 2010-06-02 | Univ Tennessee Res Foundation | Methoden zur amyloidentfernung mit anti-amyloid-antikörper |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| CN100427603C (zh) | 1999-10-04 | 2008-10-22 | 麦迪卡格公司 | 调控外源基因转录的方法 |
| KR101017732B1 (ko) * | 2002-03-01 | 2011-02-28 | 이뮤노메딕스, 인코오포레이티드 | 내재화 항-ｃｄ74 항체 및 그 이용방법 |
| JP5137400B2 (ja) | 2003-06-30 | 2013-02-06 | テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル．ピー． | アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法 |
| DE602006008460D1 (de) | 2005-06-17 | 2009-09-24 | Ca Nat Research Council | NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON |
| EP2125893A2 (en) * | 2007-01-23 | 2009-12-02 | Xencor, Inc. | Optimized cd40 antibodies and methods of using the same |
| DK2237803T3 (en) * | 2007-12-28 | 2015-10-05 | Prothena Biosciences Ltd | Treatment and prophylaxis of amyloidosis |
| US10076570B2 (en) | 2009-08-07 | 2018-09-18 | Transgene S.A. | Composition for treating HBV infection |
| WO2011119608A1 (en) | 2010-03-26 | 2011-09-29 | University Of Tennessee Research Foundation | Peptides that specifically target amyloid deposits |
| US20140079691A1 (en) | 2012-09-20 | 2014-03-20 | Anaptysbio, Inc. | Thermostable antibody framework regions |
| US9683017B2 (en) | 2014-07-17 | 2017-06-20 | University Tennessee Research Foundation | Inhibitory peptides of viral infection |
| US10213506B2 (en) | 2014-08-26 | 2019-02-26 | University Of Tennessee Research Foundation | Targeting immunotherapy for amyloidosis |
| KR20240095466A (ko) | 2017-01-30 | 2024-06-25 | 내션얼 리서치 카운슬 오브 캐나다 | 혈액-뇌 장벽을 관통이동하는 화합물 및 이의 용도 |
| RU2746325C1 (ru) * | 2017-06-29 | 2021-04-12 | Зе Трастис Оф Коламбия Юниверсити Ин Зе Сити Оф Нью-Йорк | Химерные антитела для лечения заболеваний, характеризующихся отложением амилоида |
| US11382974B2 (en) | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| IL279399B1 (en) | 2018-06-14 | 2026-04-01 | Bioatla Llc | Multispecific antibody templates |
| US12018069B2 (en) | 2018-06-28 | 2024-06-25 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for imaging amyloid deposits |
| EP4058479A4 (en) | 2019-11-15 | 2024-02-28 | University of Tennessee Research Foundation | MODIFIED IMMUNOLOBULINES FOR TARGETING AMYLOID DEPOSITS |
| JP2024521082A (ja) | 2021-05-18 | 2024-05-28 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | アミロイド障害を処置するための抗体－ペプチド融合タンパク質 |
-
2020
- 2020-11-13 EP EP20887541.9A patent/EP4058479A4/en active Pending
- 2020-11-13 BR BR112022009273A patent/BR112022009273A2/pt unknown
- 2020-11-13 JP JP2022528305A patent/JP7722990B2/ja active Active
- 2020-11-13 CN CN202080092570.1A patent/CN115298214A/zh active Pending
- 2020-11-13 MX MX2022005850A patent/MX2022005850A/es unknown
- 2020-11-13 US US17/776,827 patent/US20220411489A1/en not_active Abandoned
- 2020-11-13 WO PCT/US2020/060596 patent/WO2021097360A1/en not_active Ceased
- 2020-11-13 CA CA3158206A patent/CA3158206A1/en active Pending
- 2020-11-13 KR KR1020227019864A patent/KR20220113950A/ko active Pending
- 2020-11-13 IL IL292903A patent/IL292903B2/en unknown
- 2020-11-13 AU AU2020385183A patent/AU2020385183A1/en active Pending
-
2023
- 2023-03-09 US US18/181,489 patent/US12030934B2/en active Active
-
2024
- 2024-05-09 US US18/660,162 patent/US12264195B2/en active Active
- 2024-05-09 US US18/660,156 patent/US12157765B2/en active Active
-
2025
- 2025-02-12 US US19/052,001 patent/US20250368729A1/en active Pending
- 2025-06-20 JP JP2025104401A patent/JP2025134876A/ja active Pending